Antibody-drug conjugate developer Duality Biotherapeutics Inc. is gearing up for a second IPO attempt this year, having filed on Feb. 27 a new prospectus on the Hong Kong Stock Exchange. Two other biotechs – Genuine Biotech Ltd. and Cloudbreak Pharma Inc. – also are having another go at a listing in Hong Kong in 2025.

Biopharmas raising money in public or private financings, including: PDS Biotechnology.

Med-tech firms raising money in public or private financings, including: Trinity Biotech.